GB2444101A - Methods and compositions for detecting polynucleotides - Google Patents

Methods and compositions for detecting polynucleotides

Info

Publication number
GB2444101A
GB2444101A GB0608059A GB0608059A GB2444101A GB 2444101 A GB2444101 A GB 2444101A GB 0608059 A GB0608059 A GB 0608059A GB 0608059 A GB0608059 A GB 0608059A GB 2444101 A GB2444101 A GB 2444101A
Authority
GB
United Kingdom
Prior art keywords
change
optical property
target polynucleotide
rate
dye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0608059A
Other versions
GB0608059D0 (en
Inventor
Charles Robert Ii Bupp
K Yeon Choi
Heather Koshinsky
Christopher J Nulf
Michael S Urdea
Miaomiao Wang
Michael S Zwick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigen Inc
Original Assignee
Investigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigen Inc filed Critical Investigen Inc
Publication of GB0608059D0 publication Critical patent/GB0608059D0/en
Publication of GB2444101A publication Critical patent/GB2444101A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Methods of determining the presence or amount of a target polynucleotide in a sample are provided. A sample that contains a target polynucleotide, a nucleic acid analog that is complementary to a target nucleic acid sequence of the target polynucleotide, and a dye for which the rate of change in an optical property is different in the presence and absence of a target polynucleotide/nucleic acid analog hybrid are combined to produce a reaction mixture. The rate of change in an optical property of the dye in the reaction mixture is compared to a reference value characteristic of the rate of change in the optical property of the dye in a similar reaction mixture containing a known amount of a polynucleotide/nucleic acid analog hybrid to determine a relative rate of change in the optical property. The relative rate of change in the optical property of dye in the reaction mixture is correlated with the presence or amount of the specified target polynucleotide in the sample.
GB0608059A 2006-02-24 2006-02-24 Methods and compositions for detecting polynucleotides Withdrawn GB2444101A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/006455 WO2008041960A2 (en) 2006-02-24 2006-02-24 Methods and compositions for detecting polynucleotides

Publications (2)

Publication Number Publication Date
GB0608059D0 GB0608059D0 (en) 2006-05-31
GB2444101A true GB2444101A (en) 2008-05-28

Family

ID=36581138

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0608059A Withdrawn GB2444101A (en) 2006-02-24 2006-02-24 Methods and compositions for detecting polynucleotides

Country Status (2)

Country Link
GB (1) GB2444101A (en)
WO (1) WO2008041960A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2694526A4 (en) * 2011-04-01 2015-04-22 Advandx Inc Molecular gram stain
WO2014127214A1 (en) 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
ES2831625T3 (en) 2013-02-20 2021-06-09 Kala Pharmaceuticals Inc Therapeutic compounds and their uses
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
WO2015066482A1 (en) 2013-11-01 2015-05-07 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324716B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324251A1 (en) 2016-09-08 2019-03-21 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324713B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2528843A1 (en) * 2003-05-20 2005-02-24 Investigen, Inc. System for detecting polynucleotides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Not yet advised *

Also Published As

Publication number Publication date
WO2008041960A2 (en) 2008-04-10
WO2008041960A3 (en) 2009-05-22
GB0608059D0 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
WO2007100711A3 (en) Methods and compositions for detecting polynucleotides
GB2444101A (en) Methods and compositions for detecting polynucleotides
WO2005017181A3 (en) System for detecting polynucleotides
IL173314A0 (en) Determining the sequence of a polynucleotide
WO2006119326A3 (en) Oligonucleotide probe/primer compositions and methods for polynucleotide detection
IL204288A (en) Copy number variation determination, methods and systems
WO2008094902A3 (en) Compositions and methods for the detection of a nucleic acid using a cleavage reaction
ATE494392T1 (en) TWO-COLOR REAL-TIME/ENDPOINT QUANTIFICATION OF MICRO-RNAS (MIRNAS)
RU2017101174A (en) KIT OR DEVICE FOR LIVER CANCER DETECTION AND DETECTION METHOD
WO2011045744A3 (en) Methods and compositions for amplifying target sequences from nucleic acid samples
WO2007133703A3 (en) Detection of nucleic acid targets using chemically reactive oligonucleotide probes
MX2007009809A (en) Selection probe amplification.
WO2008054556A3 (en) Methods and compositions for detection of a target nucleic acid sequence
WO2017044993A3 (en) Nucleic acid analysis by joining barcoded polynucleotide probes
GB201017978D0 (en) Multiplex amplification and detection
WO2008103900A3 (en) Selection and enrichment of proteins using in vitro compartmentalization
WO2009100215A3 (en) Detection of clostridium difficile
WO2010034794A3 (en) Methods and kits for the diagnosis and the staging of colorectal cancer
WO2011011535A3 (en) Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range
WO2006005081A3 (en) Compositions and methods for identifying nucleotides in polynucleotide sequences
WO2010036359A3 (en) Methods of polymerase activity assay
WO2010004562A3 (en) Methods and compositions for detecting colorectal cancer
WO2007107775A8 (en) Preparation of oligonucleotides with photoswitchable properties
WO2011001449A3 (en) Pcr primers and methods of detection of salmonella
WO2007115702A3 (en) Mixture of reversibly inhibited enzymes

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)